Users of weight loss drugs say having the medication in pill form could make it cheaper, but others think it may be "annoying ...

Living with type 1 diabetes means navigating an endless mental marathon. Between calculating insulin doses and managing ...

Some pharmacies have already begun to offer it ...

A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS. The National Institute for Health and Care Excellence (NICE) has ...

The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.

A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every day ...

The NHS has approved the world's first drug to delay the onset of Type 1 diabetes for three years. The drug was given the green light on Tuesday (June 23), marking the biggest diabetes breakthrough in ...

Clinical trial evidence reviewed by an independent NICE committee shows that teplizumab can delay the onset of symptomatic type 1 diabetes by an average of nearly 3 years. Teplizumab is the ...

A childhood obesity expert reveals how NHS clinics are helping Britain’s most severely obese children – from weight-loss jabs ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The National Institute for Health and Care Excellence (NICE) has approved teplizumab (Tzield) for use in the NHS, marking a significant advancement in type 1 diabetes treatment. This first-of-its-kind ...

For more than 100 years, insulin’s been the lifeline for people with type 1 diabetes. It’s changed lives, saved millions, and become a daily reality for anyone diagnosed. But the one thing it never ...